3/2
11:44 am
mdln
Rating for MDLN
Low
Report
Rating for MDLN
3/2
11:44 am
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/27
11:13 am
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/27
11:13 am
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
03:12 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
03:12 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
01:30 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
12:49 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
12:49 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/26
10:39 am
mdln
Rating for MDLN
Medium
Report
Rating for MDLN
2/26
10:39 am
mdln
Rating for MDLN
Medium
Report
Rating for MDLN
2/26
10:35 am
mdln
Rating for MDLN
Medium
Report
Rating for MDLN
2/5
12:26 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/5
12:26 pm
mdln
Rating for MDLN
Low
Report
Rating for MDLN
2/5
10:58 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
2/5
10:58 am
mdln
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
Low
Report
Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.
2/5
09:47 am
mdln
Medline initiated with a Buy at Tigress Financial
Low
Report
Medline initiated with a Buy at Tigress Financial
2/5
09:47 am
mdln
Medline initiated with a Buy at Tigress Financial
Low
Report
Medline initiated with a Buy at Tigress Financial
1/21
09:04 am
mdln
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at BNP Paribas to a "hold" rating.
1/14
07:36 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
1/13
05:44 am
mdln
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Low
Report
Medline (NASDAQ:MDLN) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.